Trends in susceptibility of selected gram-negative bacilli isolated from intra-abdominal infections in North America: SMART 2005-2010

Tim Babinchak; Robert Badal; Daryl Hoban; Meredith Hackel; Stephen Hawser; Sibylle Lob; Samuel Bouchillon

doi:10.1016/j.diagmicrobio.2013.02.031

Trends in susceptibility of selected gram-negative bacilli isolated from intra-abdominal infections in North America: SMART 2005-2010

Diagn Microbiol Infect Dis. 2013 Jul;76(3):379-81. doi: 10.1016/j.diagmicrobio.2013.02.031. Epub 2013 Mar 27.

Authors

Tim Babinchak¹, Robert Badal, Daryl Hoban, Meredith Hackel, Stephen Hawser, Sibylle Lob, Samuel Bouchillon

Affiliation

¹ International Health Management Associates, Inc., Schaumburg, IL 60173, USA.

PMID: 23541118
DOI: 10.1016/j.diagmicrobio.2013.02.031

Abstract

This report summarizes data from the Study for Monitoring Antimicrobial Resistance Trends 2005-2010 to identify trends in susceptibility from intra-abdominal infections in North America. Escherichia coli and Klebsiella pneumoniae were the most frequently isolated pathogens. Extended-spectrum beta-lactamase rates (%) in 2005/2010 for E. coli and K. pneumoniae were 1.7/7.3 and 3.2/13.1, respectively. Ertapenem, imipenem, amikacin, and cefoxitin showed stable susceptibility.

MeSH terms

Anti-Bacterial Agents / pharmacology
Canada
Epidemiological Monitoring
Escherichia coli / drug effects*
Escherichia coli / isolation & purification
Escherichia coli Infections / epidemiology
Escherichia coli Infections / microbiology*
Gram-Negative Bacteria / drug effects
Gram-Negative Bacteria / isolation & purification
Humans
Intraabdominal Infections / epidemiology
Intraabdominal Infections / microbiology*
Microbial Sensitivity Tests
Quinolones / pharmacology
United States
beta-Lactam Resistance*
beta-Lactams / pharmacology

Substances

Anti-Bacterial Agents
Quinolones
beta-Lactams